Bioncise Nv

bioncise creates and manufactures innovative biopsy instruments with the highest sample to needle ratio (biggest sample for the smallest needle) with applications in interventional radiology, endoscopy, gynecology, oncology, and regenerative medicine. the spirotome and corticore line of products were the first instruments that became commercially available. they harvest tissues, from patients and high risk individuals, with minimal discomfort in delicate organs that never could be reached before or are too dangerous for traditional biopsy instruments. also the volume of sample increased from below 20 mg for traditional systems to over 300 mg with the spirotome. over 90% of the cells are viable and can be used for tissue engineering. the biopsy samples have the highest quality (volume, freshness and representativity) that is needed for personalized diagnostics to select cancer patients for the most optimal treatment. this selection process already can double survival and should